Advertisement
Advertisement
U.S. markets open in 4 hours 2 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Innoviva, Inc. (INVA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
14.50+0.13 (+0.90%)
At close: 04:00PM EDT
14.90 +0.40 (+2.76%)
After hours: 07:53PM EDT
Advertisement

Yahoo Finance will soon be upgrading our Conversations message board platform to provide a better experience for our users. Only comments published since April 21, 2021 will be visible on Yahoo Finance after the upgrade. If you wish to download and save any of your older comments, please submit a request via the Privacy Dashboard by no later than Aug. 15, 2022.

Sign in to post a message.
  • R
    Randy
    Waiting patiently 💰
  • P
    Paul
    Anyone who is still holding ETTX? Those who haven't participated in tender, what's next for them? Any thoughtful comment will be greatly appreciated.
  • R
    Richard
    shorts playing around, this will turn around....for sure
  • b
    bill
    Can someone tell us what happened to our ettx shares value for my shares are at $00 with td and td has no idea what they can do
  • P
    Paul
    low float makes this stock sensitive to short but intense trading. It will recover as fast as it dropped.
  • W
    Wizzles
    What will this company do after drugs go off patent to make good revenue streams? Anything solid or is it all just maybe they will make money on x or y?
  • D
    David
    $TBPH conversation
    $tbph 35% drop yest was def overdone & is clear buying opportunity. So one drug failed, but its royalties from two COPD drugs alone value its stock at $11. Plus add ampreloxetine potential. Price target was cut by 21% which is accurate so the 35% drop puts it at 14% undervalued. After the 21% cut, price target now $29 which is still a 213% upside. https://www.investors.com/news/technology/biotech-stock-theravance-crashes-after-ulcerative-colitis-drug-flops/?src=A00220 $rvnc $inva $enta $xlrn
    Bullish
  • J
    Jesse
    $ETTX conversation
    You guys should load up on $INVA tomorrow. They are one of ETTX largest stake holders. ETTX moved up 24% after hours INVA was flat. They have $25 million or $35 Million in ETTX and about that much for ARMP plus a $250 million investment Sarissa Capital believe the symbol may be SRSA. If ETTX continues advancing or gets approval may move into their royalty or acquisition portfolio which means big bucks for ETTX. Since I own INVA bought all three because I think all three will one day not too far off might be in one grouping. Good luck longs
    Bullish
  • R
    Right Stuff
    This company seems very solid on a fundamental basis. It's hard to understand why the analysts don't have more confidence in it. And their highlighted product, for COPD and asthma, seems apropos and could be huge.
    Bullish
  • J
    Jesse
    $SRSA conversation
    Wondering if this SPAC is going to be a holding company for Innoviva inc. INVA which has been hitting new highs recently. Saw in the fine print of one of INVA reports that they have funded Sarissa Capital approximately $320 million in cash to diversify their holdings. Not sure if this spac is tied to it or not. It would function as a vehicle for $INVA growth which has hit a new multi year high a few days in a row and is a cash cow bringing in about $80 million a quarter in cash after expenses. I could see INVA creating a holding company for their large position indirect holdings like ETTX and ARMP and maybe some others and combing them into one separate company and keep INVA as a pharmaceutical royalty company with their three or four licensed drugs that they have tie ins with the big pharma players. Then once potential products that get developed from the investments then INVA obtains licenses to add to their portfolio or gains a royalty. Interesting possible way to play it. bought into this thing at $11 a share early this year so sitting on a loss but if they do find a nice target it has the potential to get my money back and then some. Good luck to you all.
    Bullish
  • S
    Steven
    Argus says it is 112% discount
    If $ettx hits on p3 it will rock, inva owns 67% of ettx and warrants
  • b
    bob
    After reading comments I've learned that INVA likes owning a good piece of other companies. One I didn't see mentioned is ARMP which they bought a lot of last month at $3.25. It is now over $6. I just bought INVA today and will get more if the price drops.
    Bullish
  • B
    Big
    Why does this stock have such a high short ratio? It looks solid at first glance!
    Bullish
  • J
    John
    great quarter, cash flow, diversifying, and one day will be rewarded
  • M
    Matt
    Not mad keen on the capital allocation, especially the risky bets on antibiotic biotechs, but if they're not going to return cash to shareholders then putting it in a long term investment is probably next best.

    Sarissa Cap look to have a decent investing record based on the info I could find. Let's hope they put the cash to good use...
  • L
    Lota
    INVA buys back GlaxoSmithKline’s stake for $392Million
  • A
    Albert
    Where can I find out how much longer their patent(s) last?
  • K
    Kelly
    Looks like we will see some drops back to 12
  • r
    robert
    Nice little upside surprise.
Advertisement
Advertisement